Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Link opens in a new tab
Search content at University of Birmingham
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Novel therapies in type 2 diabetes: insulin resistance
Abd A. Tahrani
*
*
Corresponding author for this work
Metabolism and Systems Science
Centre for Endocrinology, Diabetes and Metabolism
Research output
:
Contribution to journal
›
Review article
›
peer-review
6
Citations (Scopus)
360
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Novel therapies in type 2 diabetes: insulin resistance'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Novel Therapies
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Insulin Resistance
100%
Obesity
33%
Sleep-related Disorders
33%
Lifestyle Intervention
22%
Bariatric Surgery
22%
Insulin Signaling Pathway
22%
Ectopic Fat
22%
Liver
11%
Cardiovascular Disease
11%
Protein Kinase B
11%
Cell Survival
11%
Cell Apoptosis
11%
Therapeutic Intervention
11%
Treatment Strategy
11%
Glucose Transporter 1 (GLUT1)
11%
Pharmacotherapy
11%
Insulin Sensitivity
11%
Major Risk Factors
11%
Independent Risk Factors
11%
Diabetes Disease
11%
Multiple Agents
11%
Negative Feedback
11%
Insulin Signaling
11%
Insulin Receptor
11%
Resistance Index
11%
Feedback Device
11%
Glycemic Measures
11%
Sustainable Impact
11%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Insulin Resistance
100%
Disease
33%
Lifestyle Intervention
22%
Bariatric Surgery
22%
Insulin Signaling
22%
Drug Therapy
11%
Signal Transduction
11%
Cardiovascular Disease
11%
Cell Survival
11%
Programmed Cell Death
11%
Protein Kinase B
11%
Insulin Sensitivity
11%
Cell Signaling Pathway
11%
Glycemic
11%
Insulin Receptor
11%
Glucose Transporter
11%
Negative Feedback
11%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Insulin Resistance
100%
Protein Kinase B
11%
Cardiovascular Disease
11%
Pharmacotherapy
11%
Insulin Receptor
11%
Glucose Transporter
11%